Publikationen von I. Assfalg-Machleidt

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site probing of papain-like cysteine proteases. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS 13 (1-2), S. 93 - 104 (2007)

FIORINO, F.; GIL-PARRADO, S.; ASSFALG-MACHLEIDT, I.; MACHLEIDT, W.; MORODER, L.: A new cell-permeable calpain inhibitor. Journal of Peptide Science 13, S. 70 - 73 (2007)

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site Probing of Papain-like Cysteine Proteases. Int. J. Peptide Res. & Therapeut. 13 (1-2), S. 93 - 104 (2007)

Kaiser, M.; Groll, M.; Siciliano, C.; Assfalg-Machleidt, I.; Weyher, E.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R.; Moroder, L.: Binding mode of TMC-95A analogues to eukaryotic 20S proteasome. ChemBioChem 5 (9), S. 1256 - 1266 (2004)

Kaiser, M.; Milbradt, A. G.; Siciliano, C.; Assfalg-Machleidt, I.; Machleidt, W.; Groll, M.; Renner, C.; Moroder, L.: TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors. Chemistry & Biodiversity 1 (1), S. 161 - 173 (2004)

Kaiser, M.; Siciliano, C.; Assfalg-Machleidt, I.; Groll, M.; Milbradt, A. G.; Moroder, L.: Synthesis of a TMC-95A ketomethylene analogue by cyclization via intramolecular Suzuki coupling. Organic Letters 5 (19), S. 3435 - 3437 (2003)

Gil-Parrado, S.; Assfalg-Machleidt, I.; Fiorino, F.; Deluca, D.; Pfeiler, D.; Schaschke, N.; Moroder, L.; Machleidt, W.: Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: Enhancing cell permeability by conjugation with penetratin. Biological Chemistry 384 (3), S. 395 - 402 (2003)

Kaiser, M.; Milbradt, A. G.; Renner, C.; Assfalg-Machleidt, I.; Groll, M.; Huber, R.; Moroder, L.: Cyclic biphenyl ether tripeptides as proteasome inhibitors. Biopolymers 71 (3), S. 396 - 396 (2003)

Gil-Parrado, S.; Fernandez-Montalvan, A.; Assfalg-Machleidt, I.; Popp, O.; Bestvater, F.; Holloschi, A.; Knoch, T. A.; Auerswald, E. A.; Welsh, K.; Reed, J. C. et al.; Fritz, H.; Fuentes-Prior, P.; Spiess, E.; Salvesen, G. S.; Machleidt, W.: Lonomycin-activated calpain triggers apoptosis - A probable role for Bcl-2 family members. Journal of Biological Chemistry 277 (30), S. 27217 - 27226 (2002)

Schaschke, N.; Deluca, D.; Assfalg-Machleidt, I.; Höhneke, C.; Sommerhoff, C. P.; Machleidt, W.: Epoxysuccinyl peptide-derived cathepsin B inhibitors: Modulating membrane permeability by conjugation with the C- terminal heptapeptide segment of penetratin. Biological Chemistry 383 (5), S. 849 - 852 (2002)

Kaiser, M.; Groll, M.; Götz, M.; Siciliano, C.; Assfalg-Machleidt, I.; Weyher, E.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R. et al.; Moroder, L.: Structural determinants for 20S proteasome inhibition by TMC-95A. In: Peptides 2004, S. 657 - 658 (Hg. Flegel, M.; Fridkin, M.; Gilon, C.; Slaninovva, J.). Kenes International, Geneva/Switzerland (2005)

Kaiser, M.; Groll, M.; Siciliano, C.; Götz, M.; Assfalg-Machleidt, I.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R.; Moroder, L.: Inhibition of yeast 20S proteasome by biaryl- and biaryl ether cross-bridged tripeptide derivatives as TMC-95A analogs. In: Peptides – Biology and Chemistry, S. 201 - 225 (Hg. Liu, K.-L.; J. P., T.). Science Press, USA (2005)

Pfizer, J. M.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N.: Primed-site probing of papain-like cysteine proteases. In: Peptides 2004, S. 668 - 669 (Hg. Flegel, M.; Fridkin, M.; Gilon, C.; Slaninova, J.). Kenes International, Geneva/Switzerland (2005)

Kaiser, M.; Milbradt, A. G.; Renner, C.; Assfalg-Machleidt, I.; Groll, M.; Huber, R.; Moroder, L.: Cyclic biphenyl ether tripeptides as proteasom inhibitors. In: Peptide Revolution: Genomics, Proteomics & Therapeutics, S. 348 - 349 (Hg. Chorev, M.; Sawyer, T. K.). American Peptide Society, Cardiff, Ca. (2004)